key: cord-0835816-gws44iun
authors: Kow, Chia Siang; Capstick, Toby; Hasan, Syed Shahzad
title: Are severe asthma patients at higher risk of developing severe outcomes from COVID‐19?
date: 2020-10-02
journal: Allergy
DOI: 10.1111/all.14589
sha: 5e2ccf5b665ccdeb35b373828672ae28618493d0
doc_id: 835816
cord_uid: gws44iun

nan

Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

One of the key concerns in asthma management during the novel coronavirus disease 2019 (COVID-19) pandemic is the fear for an increased risk of contracting the novel coronavirus or developing a severe course of COVID-19 in asthmatic patients, especially those receiving inhaled corticosteroids (ICS) or biological therapies. 1, 2 Therefore, the study by Heffler et al 3 to determine the incidence of COVID-19 among patients with severe asthma in Italy is highly appreciated to reveal the association between the presence of severe asthma and the acquisition of COVID-19, as well as its complications. We opined that more comprehensiveness evaluation may be needed to determine the association between the presence of severe asthma and the acquisition of COVID-19, as well as the risk for severe illness from COVID-19.

We declare there is no potential conflict of interest. 

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

Common concerns in managing bronchial asthma during the COVID-19 pandemic

COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19

Inhaled corticosteroid use and risk COVID-19 related death among 966,461 patients with COPD or asthma: an OpenSAFELY analysis